BillionToOne, Inc.(BLLN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BLLN BillionToOne, Inc.

休市中 03-20 16:00:00 EDT

76.00

+2.00

+2.70%

盘后76.00

+0.000.00%

18:50 EDT

最高76.47	最低72.59	成交量23.90万
今开74.88	昨收74.00	日振幅5.24%
总市值34.93亿	流通市值6.25亿	总股本4,597万
成交额1,807万	换手率2.91%	流通股本822.21万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BLLN","market":"US","secType":"STK","nameCN":"BillionToOne, Inc.","latestPrice":76,"timestamp":1774036800000,"preClose":74,"halted":0,"volume":239035,"hourTrading":{"tag":"盘后","latestPrice":76,"preClose":76,"latestTime":"18:50 EDT","volume":5128,"amount":389728.162,"timestamp":1774047059981,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02702702702702703,"floatShares":8222132,"shares":45965800,"eps":0.139999,"marketStatus":"休市中","change":2,"latestTime":"03-20 16:00:00 EDT","open":74.88,"high":76.47,"low":72.59,"amount":18065524.2915,"amplitude":0.052432,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.139999,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"listingDate":1762405200000,"exchange":"NASDAQ","adjPreClose":74,"preHourTrading":{"tag":"盘前","latestPrice":74,"preClose":74,"latestTime":"08:00 EDT","volume":1,"amount":74,"timestamp":1774008000927,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":76,"preClose":76,"latestTime":"18:50 EDT","volume":5128,"amount":389728.162,"timestamp":1774047059981,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0777232539319481,"impliedVol":0.8378,"impliedVolPercentile":0.2857},"requestUrl":"/m/hq/s/BLLN","defaultTab":"news","newsList":[{"id":"1186729137","title":"异动解读 | 遭两家机构下调目标价，BillionToOne盘中大跌5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186729137","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186729137?lang=zh_cn&edition=full","pubTime":"2026-03-05 22:46","pubTimestamp":1772721988,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc. (BLLN) 今日盘中股价大跌5.91%，引起了市场的关注。消息面上，据路透报道，华尔街分析师在周四调整了对多家美国公司的评级和目标价。其中，BTIG将BillionToOne的目标价从160美元下调至140美元，杰富瑞(Jefferies)也将该股目标价从117美元下调至92美元。两家机构同时下调目标价，可能反映了对该公司前景的谨慎看法，从而影响了市场情绪。分析师调整目标价是影响个股短期走势的常见因素。此次下调可能引发了部分投资者的抛售，导致股价在交易时段内承压下跌。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"1106312764","title":"财报前瞻 ｜BillionToOne, Inc.本季度营收预计持平，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1106312764","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106312764?lang=zh_cn&edition=full","pubTime":"2026-02-25 10:25","pubTimestamp":1771986330,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc.将于2026年03月04日盘后发布财报，市场关注营收与利润率边际改善及调整后每股收益的变动。根据当前市场一致预期，本季度公司营收预计为8,716.09万美元，同比为0.00%；调整后每股收益预计为0.09美元，同比为0.00%，公司上一季度未披露对本季度收入的明确指引，毛利率与净利润的本季度预测数据亦未提供。上季度公司营收为8,352.30万美元，同比为0.00%；毛利率为69.94%；归属母公司股东的净利润为150.70万美元，净利率为1.80%；调整后每股收益为0.10美元，同比为0.00%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 ｜BillionToOne, Inc.本季度营收预计持平，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"gpt_icon":1},{"id":"1197071966","title":"Billiontoone宣布选用Northstar Select®作为国立癌症研究中心东医院Lc-Scrum-TRY临床研究新型液体活检检测方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1197071966","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197071966?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:09","pubTimestamp":1767708555,"startTime":"0","endTime":"0","summary":"精准医疗企业Billiontoone近日宣布，其创新液体活检产品Northstar Select已被正式选定为国立癌症研究中心东医院开展的Lc-Scrum-TRY临床研究项目的新型检测工具。此次合作将依托Northstar Select的高灵敏度特性，对参与Lc-Scrum-TRY研究的肺癌患者进行循环肿瘤DNA监测。国立癌症研究中心东医院作为日本顶尖肿瘤研究机构，其主导的Lc-Scrum-TRY项目旨在建立肺癌治疗响应评估新范式。引入Billiontoone的液体活检技术，有望突破传统组织活检的时空局限性，实现治疗过程中肿瘤基因演变的连续追踪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"1155397923","title":"BillionToOne超灵敏液体活检技术 为日本耐药非小细胞肺癌患者拓宽精准医疗通路","url":"https://stock-news.laohu8.com/highlight/detail?id=1155397923","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155397923?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:07","pubTimestamp":1767708457,"startTime":"0","endTime":"0","summary":"BillionToOne公司推出的超灵敏液体活检技术，正在日本市场显著提升耐药性非小细胞肺癌患者获得精准医疗的机会。这项创新检测方法通过高灵敏度分析血液中的循环肿瘤DNA，能够精准识别对传统治疗方案产生抵抗的肺癌患者的特定基因突变，从而为临床医生制定个性化治疗策略提供关键依据。\n目前，该技术已开始在日本多家医疗机构推广应用，有望改变耐药非小细胞肺癌患者的治疗格局。与传统组织活检相比，液体活检具有创伤小、可重复性强等优势，特别适合需要长期监测治疗反应的患者群体。随着精准医疗理念的深入，这项技术将为更多日本肺癌患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BLLN"],"gpt_icon":0},{"id":"2581491700","title":"BillionToOne登陆纳斯达克，首日狂飙81.57%，市值升至近48亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581491700","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581491700?lang=zh_cn&edition=full","pubTime":"2025-11-07 06:00","pubTimestamp":1762466400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，生物分子诊断公司BillionToOne周四正式登陆纳斯达克，开盘股价暴涨，截至收盘，该股涨幅为81.57%，市值迅速升至近48亿美元，成为政府停摆背景下逆势上市的亮眼新股。BillionToOne此次发行价为60美元，开盘即跳涨至100美元，盘中最高逼近123.45美元。BillionToOne 目前位于加州门洛帕克，专注开发基于单分子测序技术的无创产前检测及肿瘤血液检测。在政府停摆持续、SEC审批程序受限的情况下，BillionToOne的成功上市被视为IPO市场回暖的重要信号。","market":"us","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366325.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"BillionToOne登陆纳斯达克，首日狂飙81.57%，市值升至近48亿美元","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","BLLN","BK1147"],"gpt_icon":0},{"id":"1191654904","title":"异动解读 | BillionToOne盘中大涨66.67%，IPO首日开盘价超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1191654904","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191654904?lang=zh_cn&edition=full","pubTime":"2025-11-07 01:42","pubTimestamp":1762450934,"startTime":"0","endTime":"0","summary":"分子诊断公司BillionToOne, Inc.今日在纳斯达克首次公开交易，盘中大涨66.67%，引起市场广泛关注。据悉，BillionToOne的股票开盘价为每股100美元，较60美元的发行价大幅上涨66.7%。值得注意的是，BillionToOne最初计划发行385万股，每股价格区间为49美元至55美元，但最终定价高于预期区间。总部位于加利福尼亚州门洛帕克市的BillionToOne主要开发分子诊断测试，包括针对各种疾病的无创产前筛查和液体活检。BillionToOne的强劲debut表明投资者对其业务前景及生物科技行业整体保持乐观态度。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"1131573131","title":"异动解读 | BillionToOne上市首日，股价盘中大涨66.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131573131","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131573131?lang=zh_cn&edition=full","pubTime":"2025-11-07 01:42","pubTimestamp":1762450934,"startTime":"0","endTime":"0","summary":"分子诊断公司BillionToOne今日在纳斯达克证券交易所首次亮相，股价表现亮眼，盘中大涨66.67%，引发市场广泛关注。据悉，BillionToOne的IPO发行价为每股60美元，而开盘价高达100美元，较发行价溢价66.7%。值得注意的是，BillionToOne最初计划发行385万股，每股价格区间为49美元至55美元，但最终定价明显高于预期区间。此次成功上市不仅为BillionToOne带来了可观的融资，也反映了投资者对其业务前景的看好。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BLLN"],"gpt_icon":0},{"id":"1147084798","title":"BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股","url":"https://stock-news.laohu8.com/highlight/detail?id=1147084798","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147084798?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:02","pubTimestamp":1761732155,"startTime":"0","endTime":"0","summary":"BillionToOne, Inc. - 首次公开募股包含 3,846,000 股 A 类普通股，并可选择额外 576,900 股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLLN"],"gpt_icon":0},{"id":"2576583836","title":"分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元 每股定价49至55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576583836","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576583836?lang=zh_cn&edition=full","pubTime":"2025-10-20 15:38","pubTimestamp":1760945928,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，分子诊断公司BillionToOne公布了其首次公开募股的条款。按照拟议价格区间的中点计算，BillionToOne 的完全稀释后市值将达到 27 亿美元。2019 年，该公司推出了其首款产前产品 UNITY，这是首个利用游离 DNA 进行隐性遗传病胎儿风险评估的无创产前检测，无需父亲样本或侵入性操作。BillionToOne 成立于 2016 年，专注于产前筛查和癌症治疗监测领域，其核心Quantitative Counting Templates技术能以单碱基对精度检测DNA分子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"分子诊断公司BillionToOne(BLLN.US)拟IPO融资2亿美元 每股定价49至55美元","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BLLN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.billiontoone.com","stockEarnings":[{"period":"1week","weight":0.0997},{"period":"1month","weight":-0.152},{"period":"3month","weight":-0.2593},{"period":"6month","weight":0.2667},{"period":"ytd","weight":-0.0714}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BillionToOne, Inc.于2016年作为特拉华州公司开始运营。该公司开发了一种革命性的单分子下一代测序（smNGS）平台，能够以单分子灵敏度检测和精确量化基因靶标。这项创新的核心是其专利的定量计数模板（QCT），该模板可在单个DNA分子水平上进行测量。这项技术突破了医疗保健领域在检测游离DNA中稀疏但具有临床意义的疾病信号方面的一个关键瓶颈。BillionToOne的技术平台已成功应用于一系列开创性的产前和肿瘤学产品，这些产品仅需简单的血液样本即可提供可操作的诊断信息。","exchange":"NASDAQ","name":"BillionToOne, Inc.","nameEN":"BillionToOne, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BillionToOne, Inc.(BLLN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BillionToOne, Inc.(BLLN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BillionToOne, Inc.,BLLN,BillionToOne, Inc.股票,BillionToOne, Inc.股票老虎,BillionToOne, Inc.股票老虎国际,BillionToOne, Inc.行情,BillionToOne, Inc.股票行情,BillionToOne, Inc.股价,BillionToOne, Inc.股市,BillionToOne, Inc.股票价格,BillionToOne, Inc.股票交易,BillionToOne, Inc.股票购买,BillionToOne, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BillionToOne, Inc.(BLLN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BillionToOne, Inc.(BLLN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}